Toronto Stock Exchange, Antibe Therapeutics Inc., View From The C-Suite

TORONTO, Aug. 21, 2023 /PRNewswire/ – Dan Legault, Chief Executive Officer and Director, Antibe Therapeutics Inc. (TSX: ATE) shares his Company’s story in an interview with TMX Group. The View From The C-Suite video interview series highlights the unique perspectives of listed companies…